Bioniche Life Sciences Inc. 25 Years
Contact Us Careers
Home Investors
In the News

August 25, 2008
Bioniche Animal Health Immunotherapy Now Listed as “Organic” for Use in Cattle

August 18, 2008
Bioniche Phase III Clinical Trial in Bladder Cancer Progressing Well

Investors

Check latest
stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.


Investor Contacts

Jennifer Shea
Vice-President, Communications, Investor & Government Relations
Tel: (613) 966-8058 ext. 1250 or (800) 265-5464
Fax: (613) 966-4177
Jennifer.Shea@Bioniche.com

Patrick Montpetit
Vice President & CFO
Tel: (514) 697-6636 or (866) 883-6636
Fax: (514) 697-7966
Patrick.Montpetit@Bioniche.com

Copyright 2004, Bioniche Life Sciences Inc. All rights reserved  |  Legal Disclaimer  |  Privacy Policy